lundi 27 février 2017

Onco Actu du 27 février 2017


1. Biologie

New structural studies reveal workings of a molecular pump that ejects cancer drugs [The Rockefeller University]

Discovery of distinct cell subtypes around tumors helps explain why pancreatic cancer is so hard to treat [CSHL]

The Cell Atlas [MIT Technology Review]

3.1 Tabac

NHS 'tobacco free' campaign launched by Public Health England [BBC News]

5.2 Pharma

J&J leads $25M Series A in targeted radiotherapy startup [FierceBiotech]

5.2.1 Pharma - Partenariats

Sanofi and Lonza to build new $285 million Swiss biologics facility [Reuters]

5.2.3 Pharma - économie

Pharma heads write to Congress... and put foot in mouth [Forbes]

5.3.4 Traitements - AMM (FDA, EMA)

REVLIMID® (Lenalidomide) Approved by the European Commission as Monotherapy for the Maintenance Treatment of Patients with Newly Diagnosed Multiple Myeloma after Autologous Stem Cell Transplantation [Celgene]

FDA Approves Lenalidomide as Maintenance Therapy for Patients with Multiple Myeloma Following Autologous Stem Cell Transplant [ESMO]

6.10 Politiques

Cancer patients could be significantly disadvantaged by Brexit, say experts [The Guardian]

6.10.1 Politiques (USA)

Cancer can bankrupt its victims. Obamacare was designed to stop that. [Vox]

Cancer patients, survivors fear GOP efforts to dismantle the Affordable Care Act [Washington Post]

6.4 Médico-éco

Cancer treatment is changing and coverage must change with it [The Hill]

6.7 DMP, Big Data & applis

NHS misplaced half a million patient documents [BBC News]